key articles
Mixed results for new OAB drugs
Monday, 30 May 2011- Overactive bladder (OAB) symptoms declined significantly within four weeks after the start of treatment with the investigational beta-3 agonist mirabegron, data from a randomised, placebo-controlled trial...
Edited by: JV
Immediate effect on OAB symptoms following use of imidafenacin
Monday, 2 May 2011- One of the factors influencing the treatment compliance of patients with overactive bladder (OAB) symptoms is thought to be the time to reach clinical effectiveness after administering drugs.
Y. Kitagawa and...
Edited by: JV
Caffeine intake, and the risk of stress, urgency and urinary incontinence
Friday, 22 April 2011- Although caffeine consumption is common and generally believed to affect bladder function, little is known about caffeine intake and incident urinary incontinence. Y. Jura and colleagues conducted a study...
Edited by: JV
Assessing the efficacy and tolerability of trospium XR in OAB
Wednesday, 13 April 2011- Once-daily extended-release (XR) trospium chloride has been evaluated for the treatment of overactive bladder syndrome (OAB) in two 12-week randomised, double-blind, placebo-controlled studies. This...
Edited by: JV
26th Annual EAU Congress: efficacy and safety of mirabegron in OAB
Monday, 28 March 2011- At the 26th Annual EAU Congress in Vienna, selected abstracts were highlighted for presenting some remarkable findings. Below is an extract of Abstract 885 by V. Nitti and colleagues on improvement of OAB...
Edited by: JV
No link between overactive bladder and hyperlipidemia
Wednesday, 16 March 2011- S. Garnica and colleagues conducted a study to determine the relationship between overactive bladder (OAB), with or without urinary incontinence (UI), and hyperlipidemia. They published their...
Edited by: JV
Patient’s perception of intensity of urgency scale in OAB
Friday, 19 November 2010- A group of researchers conducted a study to assess the measurement characteristics of the Patient Perception of Intensity of Urgency Scale (PPIUS) in patients with overactive bladder (OAB).
R....
Edited by: JV
Botox-A injections in neurogenic OAB: to include or exclude the trigone?
Wednesday, 17 November 2010- Taha A. Abdel-Meguid conducted a study to examine the short-term outcomes of initial detrusor injections versus combined detrusor-trigone botulinum toxin-A injections in patients with spinal cord...
Edited by: JV
Timer may help kids' bladder control
Monday, 6 September 2010- Wearing a programmable wristwatch could help children manage their daytime bladder control problems, a new study suggests.
For children with urinary incontinence, the first approach to treatment is...
Edited by: ES
Treatment of recurrent urinary incontinence after artificial urinary sphincter placement
Friday, 20 August 2010- B. Christinea and L. Knoll conducted a study on the use of the AdVance male sling to treat men who had an artificial urinary sphincter placed and subsequently developed recurrent urinary...
Edited by: JV
